Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 610 of 1,261
  1. US 9757420

    Gene editing for HIV gene therapy

    Sangamo Therapeutics, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  2. US 9757407

    Treatment of viral infections by modulation of host cell metabolic pathways

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  3. US 9757383

    Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

    Almirall, S.A. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  4. US 9757379

    Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)

    The Board of Regents of the University of Texas System · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  5. US 9757475

    Templated nanoconjugates

    Northwestern University · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  6. US 9757377

    Solid preparation

    Takeda Pharmaceutical Company Limited · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  7. US 9757354

    Therapeutic formulations and methods

    Regents of the University of Minnesota · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  8. US 9757366

    Methods for the treatment of parkinson's disease psychosis using pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  9. US 9757351

    Medical device rapid drug releasing coatings comprising oils, fatty acids and/or lipids

    Lutonix, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  10. US 9757336

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  11. US 9757209

    Compositions and methods for dental applications involving zinc-oxide cements

    Essential Dental Systems, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  12. US 9752147

    RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

    Arrowhead Pharmaceuticals, Inc. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  13. US 9751970

    Block copolymer and micelle compositions and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  14. US 9751932

    Anti-big-endothelin-1 (big-ET-1) antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  15. US 9751931

    Hepatitis C virus neutralizing antibodies and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  16. US 9751893

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  17. US 9751885

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  18. US 9750845

    Biodegradable nanocomposites with enhanced mechanical properties for soft tissue engineering

    Northwestern University · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  19. US 9750810

    Compositions and methods for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  20. US 9751851

    Molecules and compositions that inhibit gram negative bacteria and their uses

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  21. US 9750849

    Oxygen generating biomaterial

    The Board of Regents of the University of Texas System · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  22. US 9750793

    Multifunctional oral vaccine based on chromosome recombineering

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  23. US 9750748

    Pyridazinones as DAAO enzyme inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  24. US 9750717

    Inhibitors of CD40-TRAF6 interaction

    Ludwig-Maximilians-Universitat Munchen · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.